Melbourne New study shows, an anti-parasitic drug can kill the Corona virus in 48 hours.
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI), a collaboration between the University of Melbourne and Royal Melbourne Hospital has shown that there are anti-parasitic drugs that can kill the corona virus within 48 hours. The researchers said the drug was available worldwide.
Study leader Dr Kylie Wagstaff from the Monash Biomedicine Discovery Institute said the scientists indicated that the anti-parasitic drug in question was Ivermectin. The drug is able to stop the growth of SARS-CoV-2 that occurs in cell culture for 48 hours.
“We found that a single dose of Ivermectin basically killed the RNA virus within 48 hours. In the first 24 hours we even found a very significant weakening effect,” said Dr. Wagstaff, as in an official release received by HealthAdore.com
Ivermectin has been FDA approved and has been proven effective in vitro for treating various viruses including HIV, Dengue, Influenza, and Zika. However, Dr. Wagstaff said that the tests carried out were still in vitro and needed further testing for the use of doses on humans.
According to him, Ivermectin is already widely used and is believed to be a safe drug.
“We need to find out now about the exact dosage dose that can be used for humans effectively – that is the next step,” said Dr Wagstaff.
“When we are experiencing a global pandemic and there is no approved medical drug as of now, the presence of a compound that is widely available can help many people quickly. This is also driven by the condition that we need a long time for the presence of the vaccine broadly, “he added.
Not yet known how it works on COVID-19
The way Ivermectin works in the corona virus is unknown. However, based on its reaction to other viruses, Ivermectin effectively stops viruses that ‘weaken host cells’ and cleanse them, explained Wagstaff.
Citing the WebMD page, Ivermectin is commonly used to treat infections due to parasitic types such as infections caused by roundworm worms in humans. Ivermectin belongs to the class of antihelmintics drugs that work to weaken and kill parasites.
The use of this drug to treat parasites is by oral means or taken on an empty stomach at least one hour before eating. Ivermectin is usually taken in a single or radiant dose, as prescribed by the doctor.
The first author of this collaborative study, Dr. Leon Caly is a dotker from Royal Melbourne Hospital. He is also a senior medical scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty Institute, where experiments with live corona viruses are carried out.
“As a virologist who was part of the first team to isolate and share SARS-CoV-2 cases outside of China in January 2020, I have great hopes about the prospect of Ivermection being used as a potential drug to treat sufferers of COVID-19, said Dr. Caly.
Previously, Wagstaff had a breakthrough discovery related to Ivermection in 2012 when he was able to identify the drug and its antiviral activity. The findings were made with Professor David Jans of the Monash Biomedicine Discourse Institute who also wrote this new paper. Professor Jans and his team have been researching Ivermectin for more than 10 years with various types of viruses.
As soon as the pandemic was discovered, Wagstaff and Jans began to investigate whether the virus worked on the SARS-CoV-2 virus.